Stratasys Ltd.
SSYSTechnologyNASDAQComputer Hardware
Scan Results
Daily timeframeStratasys Ltd. provides connected polymer-based 3D printing solutions. At a $700.7M market cap, Stratasys Ltd. ranks as a small-cap company within technology. It offers range of 3D printing systems, including polyjet printers, fused deposition modeling (FDM) printers designed for prototyping, manufacturing tools, and production parts; PolyJet printers to print multiple materials including color printing in a single part build; pantone having validated colors, and multiple material properties; TechStyleTM, which allows 3D printing directly on different kinds of fabrics, enabling series productions in the fashion industry; Anatomy, which helps medical device companies optimize design throughout the product lifecycle; GelMatrix resin; TissueMatrix resin; BoneMatrix resin; and Digital Anatomy Creator to create different anatomical structures by customizing specific bio-mechanical properties and color.
Market Cap
$700.7M
Beta
1.94
P/E (TTM)
—
P/E (Fwd)
42.67
EPS (TTM)
$-1.41
EPS (Fwd)
$0.19
ROE
-13.4%
ROA
-4.0%
Cash
$212.5M
Total Debt
$25.4M
Free CF
$15.0M
52W Change
-24.6%
Annual Financials
Cash vs Debt
Where SSYS stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, SSYS finished 14.07% below its 150-day moving average ($8.81) and 15.70% below its 200-day moving average ($8.98). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SSYS overbought or oversold?
At the September 3, 2026 close, SSYS's RSI(14) was 18.5, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The balance sheet looks solid with $212.5M in cash comfortably exceeding the $25.4M debt load. A net cash position generally provides financial flexibility during uncertain economic periods. Free cash flow comes in at $15.0M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -13.4% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $651.5M (2022) to $551.1M (2025), a 15% decline worth watching.
A beta of 1.94 means SSYS is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. No single metric tells the full story. Reviewing SSYS's risk profile alongside its fundamentals and technical indicators provides a more complete picture.